Point of Care Molecular Diagnostics Market Industry Analysis with Abaxis, Inc., Bayer, Bayer Crop Science, Sysmex Corporation, bioMérieux, Bio-Rad Laboratories, Danaher Corporation

The Point of Care (PoC) Molecular Diagnostics Market is set to exceed USD 2.5 billion by 2024; according to a new research study published by Global Market Insights, Inc. Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.

Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which escalates disease spreading risk. Point of care molecular diagnostic assays permit the timely detection of the causative agent enabling effective disease control.Several organizations such as Foundation for Innovative New Diagnostics conduct various initiatives and programs for creating awareness regarding pre-disease detection which will augment industry expansion in the coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2210

Polymerase Chain Reaction (PCR) technology held the largest share in 2016 and is slated to witness rapid growth over the coming years owing to its extended application and improved precision and reproducibility. Growing incidence of infectious disease and genetic disorders coupled with increase in public-private investment in PCR oriented research will propel segment growth. Chips and microarrays will witness significant growth during the forecast period as they are at the forefront of the ongoing revolution in life science and molecular biology.

Flu molecular diagnostics market held significant share in 2016. The segment is poised to grow at a rapid pace owing to the increase global burden of seasonal influenza. Flu prevalence is growing among the ageing population, new born children and individuals afflicted with certain chronic conditions who have a higher susceptibility to the disease. Increasing availability of screening tests for A and B virus infectious should further stimulate Flu PoC test demand.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Abaxis, Inc.
• Kalila Medical (Abbott Laboratories)
• Bayer
• Bayer Crop Science
• Sysmex Corporation
• bioMérieux
• Bio-Rad Laboratories
• Danaher Corporation
• ORASURE TECHNOLOGIES, INC.
• Roche Diagnostics Middle East

Candida molecular diagnostics market will witness profitable growth as it is one of the most serious health acquired infection in immuno-compromised individuals across the globe. Ongoing advancements in Candida detection focused on the development of portable point of care tests which are compact and simple to use for rapid and precise testing will drive segment growth. Firms are engaged in rigorous research and development for devising automatic platforms that automatically performs all the processes such as cell lysis, DNA / RNA extraction, purification along with detection.

Hepatitis B infection is also amongst the most important global health problems affecting large population pool. Laboratory detection of HBV is based on immune detection of HBsAg. However, the problem of HBsAg non-detection owing to diagnostic escape mutations in the isotopes or low antigen levels have greatly emphasized importance of molecular biology tools for virus detection stimulating the demand.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2210

U.S. point of care molecular diagnostics market held significant revenue share in 2016. Growing infectious disease incidence leading to huge healthcare costs and increasing focus on preventive care to reduce the economic burden are propelling the PoC molecular diagnostics market size. Increasing demand for fast and portable tests along with rising diagnostics adoption rate for use in and outside hospital settings serves as a highly influential factor driving industry growth.

Point of Care (PoC) Molecular Diagnostics Market by Technology

Polymerase Chain Reaction (PCR)
Real Time PCR
DNA / RNA Purification
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.